StarBurst® XL RFA Device

Its real-time, multi-point temperature feedback system ensures sustained target temperatures during the procedure. The patented temperature based end point provides predictable volumes of ablation with low local recurrence rates. Needle track ablation, adjustable array size, and temperature based technology of the revolutionary, first-generation StarBurst XL RFA electrode assures a high level of confidence that coagulative necrosis is taking place throughout the targeted radiofrequency interstitial tissue ablation.

Radiofrequency (RF) Ablation is a widely used thermal ablation technique that destroys targeted tissue by delivering high-frequency alternating current through a catheter or probe. The electrical energy creates heat, leading to localized coagulative necrosis and cell death. In cardiology, RF ablation is a cornerstone treatment for arrhythmias like atrial fibrillation, while in oncology, it’s used to treat tumors in the liver, kidney, lung, and other organs. RF ablation is valued for its precision, proven track record, and ability to be performed in a minimally invasive setting, often under imaging guidance.

AngioDynamics is a trusted leader in minimally invasive medical devices, specializing in advanced solutions for vascular, oncology, and surgical care. Their innovative product portfolio includes the BioFlo® catheter technology for enhanced vascular access, the AngioVac® system for venous thrombus removal, and the NanoKnife® System, a pioneering technology for tumor ablation using irreversible electroporation. Committed to improving patient outcomes and providing cutting-edge tools for healthcare professionals, AngioDynamics delivers high-quality, effective solutions that address some of the most challenging conditions in modern medicine. Browse Synergy Surgical’s collection of AngioDynamics products, including Balloons, Drainage, Dialysis, Ports and much more.